IBDEI0ZR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16812,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,16813,0)
 ;;=E87.5^^70^792^25
 ;;^UTILITY(U,$J,358.3,16813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16813,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,16813,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,16813,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,16814,0)
 ;;=E87.6^^70^792^32
 ;;^UTILITY(U,$J,358.3,16814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16814,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,16814,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,16814,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,16815,0)
 ;;=G81.91^^70^792^11
 ;;^UTILITY(U,$J,358.3,16815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16815,1,3,0)
 ;;=3^Hemiplegia affecting rt dominant side, unspec
 ;;^UTILITY(U,$J,358.3,16815,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,16815,2)
 ;;=^5004121
 ;;^UTILITY(U,$J,358.3,16816,0)
 ;;=G81.92^^70^792^9
 ;;^UTILITY(U,$J,358.3,16816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16816,1,3,0)
 ;;=3^Hemiplegia affecting lft dominant side, unspec
 ;;^UTILITY(U,$J,358.3,16816,1,4,0)
 ;;=4^G81.92
 ;;^UTILITY(U,$J,358.3,16816,2)
 ;;=^5004122
 ;;^UTILITY(U,$J,358.3,16817,0)
 ;;=G81.93^^70^792^12
 ;;^UTILITY(U,$J,358.3,16817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16817,1,3,0)
 ;;=3^Hemiplegia affecting rt nondom side, unspec
 ;;^UTILITY(U,$J,358.3,16817,1,4,0)
 ;;=4^G81.93
 ;;^UTILITY(U,$J,358.3,16817,2)
 ;;=^5004123
 ;;^UTILITY(U,$J,358.3,16818,0)
 ;;=G81.94^^70^792^10
 ;;^UTILITY(U,$J,358.3,16818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16818,1,3,0)
 ;;=3^Hemiplegia affecting lft nondom side, unspec
 ;;^UTILITY(U,$J,358.3,16818,1,4,0)
 ;;=4^G81.94
 ;;^UTILITY(U,$J,358.3,16818,2)
 ;;=^5004124
 ;;^UTILITY(U,$J,358.3,16819,0)
 ;;=H91.90^^70^792^7
 ;;^UTILITY(U,$J,358.3,16819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16819,1,3,0)
 ;;=3^Hearing loss, unspec ear, unspec
 ;;^UTILITY(U,$J,358.3,16819,1,4,0)
 ;;=4^H91.90
 ;;^UTILITY(U,$J,358.3,16819,2)
 ;;=^5006943
 ;;^UTILITY(U,$J,358.3,16820,0)
 ;;=I10.^^70^792^27
 ;;^UTILITY(U,$J,358.3,16820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16820,1,3,0)
 ;;=3^Hypertension, essential (primary)
 ;;^UTILITY(U,$J,358.3,16820,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,16820,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,16821,0)
 ;;=K64.8^^70^792^15
 ;;^UTILITY(U,$J,358.3,16821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16821,1,3,0)
 ;;=3^Hemorrhoids, oth
 ;;^UTILITY(U,$J,358.3,16821,1,4,0)
 ;;=4^K64.8
 ;;^UTILITY(U,$J,358.3,16821,2)
 ;;=^5008774
 ;;^UTILITY(U,$J,358.3,16822,0)
 ;;=K64.4^^70^792^14
 ;;^UTILITY(U,$J,358.3,16822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16822,1,3,0)
 ;;=3^Hemorrhoidal Skin Tags,Residual
 ;;^UTILITY(U,$J,358.3,16822,1,4,0)
 ;;=4^K64.4
 ;;^UTILITY(U,$J,358.3,16822,2)
 ;;=^269834
 ;;^UTILITY(U,$J,358.3,16823,0)
 ;;=I95.9^^70^792^33
 ;;^UTILITY(U,$J,358.3,16823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16823,1,3,0)
 ;;=3^Hypotension, unspec
 ;;^UTILITY(U,$J,358.3,16823,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,16823,2)
 ;;=^5008080
 ;;^UTILITY(U,$J,358.3,16824,0)
 ;;=K40.90^^70^792^37
 ;;^UTILITY(U,$J,358.3,16824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16824,1,3,0)
 ;;=3^Uniltrl Ing hernia, w/o obst/ganr, not spcf as recur
 ;;^UTILITY(U,$J,358.3,16824,1,4,0)
 ;;=4^K40.90
 ;;^UTILITY(U,$J,358.3,16824,2)
 ;;=^5008591
 ;;^UTILITY(U,$J,358.3,16825,0)
 ;;=K40.20^^70^792^4
 ;;^UTILITY(U,$J,358.3,16825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16825,1,3,0)
 ;;=3^Biltrl Ing hernia, w/o obst/ganr, not spcf as recur
 ;;^UTILITY(U,$J,358.3,16825,1,4,0)
 ;;=4^K40.20
